[go: up one dir, main page]

Youa et al., 2005 - Google Patents

Expression of interleukin-17B in mouse embryonic limb buds and regulation by BMP-7 and bFGFq

Youa et al., 2005

View PDF
Document ID
4073298632327756110
Author
Youa Z
DuRainea G
Tienb J
Leea C
Moseleya T
Reddia A
Publication year
Publication venue
Biochemical and Biophysical Research Communications

External Links

Snippet

Abstract Interleukin-17B (IL-17B) is a member of interleukin-17 family that displays a variety of proinflammatory and immune modulatory activities. In this study, we found that IL-17B mRNA was maximally expressed in the limb buds of 14.5 days post coitus (dpc) mouse …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Similar Documents

Publication Publication Date Title
Kelley Transformin Growth Factor-β
Gallucci et al. IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice
JP4235689B2 (en) Bone morphogenetic protein for treating bone disease
KR102480812B1 (en) Medical use of syndecan-2
EP2497780B1 (en) TDF-related compounds and analogs thereof
US8536128B2 (en) Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders
Miyazaki et al. Transforming growth factor-β1 stimulates or inhibits cell growth via down-or up-regulation of p21/Waf1
Wang et al. BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor
CA2225377A1 (en) Novel tgf-.beta. like cytokine
CA2856329A1 (en) Compositions and methods for treating glioma
Schäffler et al. The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21. 3-q23, a susceptibility locus identified for familial combined hyperlipidaemia (FCH)
You et al. Expression of interleukin-17B in mouse embryonic limb buds and regulation by BMP-7 and bFGF
JP2009142287A (en) Frazzled nucleotide sequences, expression products, compositions and uses
WO2000021553A2 (en) Method of regulating smn gene expression
Youa et al. Expression of interleukin-17B in mouse embryonic limb buds and regulation by BMP-7 and bFGFq
KR20160062517A (en) A pharmaceutical composition for inhibition of vascular calcification comprising dpp-4 inhibitor as an effective component
Andrew et al. Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway
AU2012201060B2 (en) TDF-related compounds and analogs thereof
Nakatani et al. Genomic organization and promoter analysis of mouse follistatin-related gene (FLRG)
Brachet et al. Nerve Growth Factor Synthesis and Biological Activity in Malignant Cells
US20090214495A1 (en) Vascular endothelial growth factor-d (vegf)-d and functionally fragments thereof for bone repairing
KR101695099B1 (en) Novel Marker for Osteoblast Differentiation and Use Thereof
Jakowlew Kensington, MD 20895
Das et al. A STAT5-Smad3 Dyad Regulates Adipogenic Plasticity and Immune Regulatory Properties of Visceral Mesenchymal Stromal Cells Under Chronic Inflammation
JP2005526488A (en) Methods for expressing LIM mineralized proteins in non-osseous cells